课题基金 / 基金详情

Pathophysiology of insulin-regulated renal blood flow and sodium excretion

Pathophysiology of insulin-regulated renal blood flow and sodium excretion
胰岛素调节肾血流量和钠排泄的病理生理学
批准号:
10206134
负责人:
Michael W. Brands
金额:
$37.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-07-01 至 2023-06-30

项目摘要

项目成果

Michael W. Brands的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract Impaired regulation of renal blood flow (RBF) is recognized as a critical element in the pathologies of diabetes and metabolic syndrome through effects on glomerular pressure, GFR, and urinary sodium excretion (UNaV). The mechanism for impaired RBF regulation in these conditions is not known. We have evidence for a novel physiological effect of insulin on RBF that may translate to mechanisms for pathophysiological RBF impact. Our data suggest that preventing excess sodium loss after meals is the physiological function of insulin- regulated UNaV. This is not due solely to tubular sodium reabsorption, as the literature would predict. We show that insulin also exerts renal vasoconstrictor tone after meals, possibly via thromboxane (TXA2), that limits the degree of meal-induced renal vasodilation. Impairment, of that physiological function should cause excessive renal vasodilation after meals, causing renal salt wasting and potential long-term implications on the progression of CKD. Exaggeration of this physiological function should cause overt renal vasoconstriction, sodium retention, and hypertension if sustained. Additional data show that blocking the protective role of nitric oxide (NO) enables high-sucrose diet to cause hypertension, which we can prevent by blocking hyperinsulinemia. We will test the central hypothesis that: The physiological, sodium-conserving effect of insulin is mediated in part by a post-meal renal vasoconstrictor influence that limits the degree of meal-induced renal vasodilation. Counterbalancing input from nitric oxide is required to prevent overt renal vasoconstriction and hypertension. The specific aims will test whether: Aim 1: The physiological, sodium-conserving effect of insulin is mediated in part by a post-meal renal vasoconstrictor influence. The experiments will test the hypotheses that: a. Preventing the meal-induced increase in plasma insulin will cause greater and more sustained increases in RBF and greater UNaV than occurs in normal control rats. b. The insulin-dependent renal vasoconstrictor influence requires TXA2. c. Under conditions of background NOS inhibition, glucose bolus will cause overall renal vasoconstriction and amplified sodium retention. d. ENaC mediates the tubular reabsorption component of the acute sodium-conserving effect of insulin. Aim 2: Impaired NO synthesis causes insulin-dependent renal vasoconstriction and hypertension during high-sucrose intake. Experiments test the hypotheses that: a. NOS inhibition will enable chronic high-sucrose intake to cause hypertension (DSI telemetry, 24 hr/day). b. Blocking hyperinsulinemia will prevent the hypertensive response to high-sucrose intake. Restoring only intra-renal hyperinsulinemia restores the hypertension response. c. TXA2 synthase inhibition will prevent the hypertensive effect of chronic high-sucrose intake.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathophysiology of insulin-regulated renal blood flow and sodium excretion
  • 批准号:
    10440320
  • 项目类别:
  • 资助金额:
    $37.75万
  • 财政年份:
    2020
  • 负责人:
    Michael W. Brands
  • 依托单位:
Animals and Instrumentation Core
  • 批准号:
    10094226
  • 项目类别:
  • 资助金额:
    $29.34万
  • 财政年份:
    2017
  • 负责人:
    Michael W. Brands
  • 依托单位:
Damage-Associated Molecular Patterns in Hypertension
  • 批准号:
    10094220
  • 项目类别:
  • 资助金额:
    $188.85万
  • 财政年份:
    2017
  • 负责人:
    Michael W. Brands
  • 依托单位:
Peach State Bridges to the Doctorate
  • 批准号:
    9750021
  • 项目类别:
  • 资助金额:
    $20.82万
  • 财政年份:
    2015
  • 负责人:
    Michael W. Brands
  • 依托单位:
海外基金